Abhay R. Kulkarni

Mumbai, MH 400709, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

An inhibitor of RORγ for chronic pulmonary obstructive disease treatment.

An inhibitor of RORγ for chronic pulmonary obstructive disease treatment.

Journal: Scientific reports

Published: October 26, 2021

Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD.

Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD.

Journal: Bioorganic & medicinal chemistry letters

Published: July 04, 2018

A radiographic survey of agenesis of the third molar: A panoramic study.

A radiographic survey of agenesis of the third molar: A panoramic study.

Journal: Journal of forensic dental sciences

Published: April 17, 2018

Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series - Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2.

Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series - Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2.

Journal: Bioorganic & medicinal chemistry letters

Published: January 17, 2018

Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1.

Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1.

Journal: Bioorganic & medicinal chemistry letters

Published: August 14, 2017

Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model.

Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model.

Journal: Bioorganic & medicinal chemistry letters

Published: December 07, 2016

Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases.

Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases.

Journal: European journal of medicinal chemistry

Published: November 15, 2016

A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives.

A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives.

Journal: European journal of medicinal chemistry

Published: October 06, 2016

Evaluation of Telmesartan Monotherapy on Morning Blood Pressure Surge in Patients with Mild to Moderate Hypertension.

Evaluation of Telmesartan Monotherapy on Morning Blood Pressure Surge in Patients with Mild to Moderate Hypertension.

Journal: Journal of the American Society of Hypertension : JASH

Published: September 28, 2016

A Study of Microalbuminuria (MAU) and Advanced Glycation End Products (AGEs) Levels in Diabetic and Hypertensive Subjects.

A Study of Microalbuminuria (MAU) and Advanced Glycation End Products (AGEs) Levels in Diabetic and Hypertensive Subjects.

Journal: Indian journal of clinical biochemistry : IJCB

Published: September 16, 2016

Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2',3':3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor.

Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2',3':3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor.

Journal: Bioorganic & medicinal chemistry letters

Published: August 02, 2016

Blocking TRPA1 in Respiratory Disorders: Does It Hold a Promise?

Blocking TRPA1 in Respiratory Disorders: Does It Hold a Promise?

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 14, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026